Lixivaptan
PA-ADPKD-301
Phase 3 small_molecule terminated
Quick answer
Lixivaptan for Autosomal Dominant Polycystic Kidney is a Phase 3 program (small_molecule) at Centessa Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Centessa Pharmaceuticals plc
- Indication
- Autosomal Dominant Polycystic Kidney
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated